Review Article
The Human Skin-Derived Precursors for Regenerative Medicine: Current State, Challenges, and Perspectives
Table 3
The protocols for neurogenesis of hSKPs.
| Differentiation | Basic medium | Reagent (concentration) | Indication | Ref. |
| Neuron differentiation | Neurobasal or DMEM/F12 (3 : 1) medium | Brain-derived neutrophic factor (50 ng/ml), nerve growth factor (50 ng/ml), neurotrophiin-3 (10 ng/ml), FBS (1%–5%) | Differentiation for 2–4 weeks with 50% of the medium changed every 3-4 days | [6] | Schwann cell differentiation | Neurobasal or DMEM/F12 (3 : 1) medium | N2 supplement (1% or 2%), forskolin (4 μm or 5 μm), heregulinβ (10 ng/ml or 50 ng/ml), FBS (1%) | Differentiation for 2–4 weeks with 50% of the medium changed every 3-4 days | [6, 34] | Astrocyte differentiation | B27 neurobasal medium | FBS (3%–10%) | Differentiation for 3 weeks with 50% of the medium changed every 3-4 days | [32] |
|
|
DMEM: Dulbecco’s modified Eagle medium; FBS: fetal bovine serum.
|